828 Tumor targeted superantigen (TTS) enhances CAR-T cell activity against solid tumors in vivo

828 Tumor targeted superantigen (TTS) enhances CAR-T cell activity against solid tumors in vivo

Bibliographic Details
Main Authors:	Meir Azulay, Yael Sagi, Michal Shahar, Dana Greenfeld, Eitan Shany, Shay Bamany
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

576 Tumor Targeted Superantigen (TTS), Naptumomab Estafenatox (NAP), enhances CAR-T cells potency and can boost CAR-T efficacy against solid tumors
by: Yael Sagi, et al.
Published: (2021-11-01)

Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading
by: Meir Azulay, et al.
Published: (2023-03-01)

SUPERANTIGENS
by: Mojca NARAT
Published: (1998-12-01)

ANTITHROMBOTIC ACTIVITY OF SBT-828 COMPOUND
by: V. S. Sirotenko, et al.
Published: (2015-09-01)

Staphylococcal Superantigen-like 10 Inhibits CXCL12-Induced Human Tumor Cell Migration
by: Annemiek M.E. Walenkamp, et al.
Published: (2009-04-01)

6.828 Operating System Engineering, Fall 2006
by: Kaashoek, Frans
Published: (2006)

6.828 Operating System Engineering, Fall 2003
by: Kaashoek, Frans, 1965-
Published: (2003)

Animating mouth shape for TTS system
by: Deepana Naidu
Published: (2014)

258 Enhancing tumor infiltration of CAR T cells in solid tumors
by: Ananda Goldrath, et al.
Published: (2023-11-01)

L8 F828 (3-14) [fotograf udara]
by: Malaysia. Direktorat Pemetaan Negara

L11 F828 (37-56) [fotograf udara]
by: Malaysia. Direktorat Pemetaan Negara

Recognition of antigen and superantigen by cytotoxic lymphocytes
by: Bowness, P, et al.
Published: (1993)

SUPERANTIGENS - PATHOGENICITY FAKTORS OR STIMULATORS OF IMMUNITY?
by: A. V. Pronin
Published: (2014-07-01)

Superantigens and SARS-CoV-2
by: Adam Hamdy, et al.
Published: (2022-03-01)

Superantigens, a Paradox of the Immune Response
by: Sofia Noli Truant, et al.
Published: (2022-11-01)

Superantigens and Streptococcal Toxic Shock Syndrome
by: Thomas Proft, et al.
Published: (2003-10-01)

Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
by: Yuna Jo, et al.
Published: (2020-07-01)

US Patent 8,165,828 Compensating for frequency change in flowmeters
by: Tombs, M
Published: (2012)

L8A F828 (156-162) [fotograf udara]
by: Malaysia. Direktorat Pemetaan Negara

236 In vivo-generated TagCAR T cells inhibit solid tumor growth following treatment with bispecific small molecule TumorTags
by: Andrew Scharenberg, et al.
Published: (2023-11-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

CAR T-Cell Therapy in Children with Solid Tumors
by: Marika Kulczycka, et al.
Published: (2023-03-01)

CAR T Cell Locomotion in Solid Tumor Microenvironment
by: Duy T. Nguyen, et al.
Published: (2022-06-01)

IDENTIFICATION OF A NOVEL CLOSTRIDIAL ENTEROTOXIN SUPERANTIGEN
by: Bowness, P, et al.
Published: (1992)

Convergent capture of retroviral superantigens by mammalian herpesviruses
by: Aswad, A, et al.
Published: (2015)

Superantigens : molecular basis for their role in human diseases /
by: Fraser, John D., et al.
Published: (2007)

Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens
by: Stephen W. Tuffs, et al.
Published: (2018-05-01)

Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils
by: Yanling Liang, et al.
Published: (2023-11-01)

Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo.
by: Michie, C, et al.
Published: (1994)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
by: Abigail Cheever, et al.
Published: (2022-11-01)

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
by: Ting Yan, et al.
Published: (2023-01-01)

Rule-Based Turkish Text Summarizer (RB-TTS)
by: BIRANT, C. C., et al.
Published: (2018-08-01)

Software engineering standards : ANSI/IEEE Stds 729-730, 828-830
Published: (1984)

Breakthrough of solid tumor treatment: CAR-NK immunotherapy
by: Wenkang Wang, et al.
Published: (2024-01-01)

Recent Advances in CAR-Based Solid Tumor Immunotherapy
by: Min Hwa Shin, et al.
Published: (2023-06-01)

262 CAR-mast cell therapy for solid tumors
by: Jianjian Guo, et al.
Published: (2023-11-01)

Delivering CAR‐T cells into solid tumors via hydrogels
by: Shun‐Yu Wu, et al.
Published: (2023-06-01)

Blocking Superantigen-Mediated Diseases: Challenges and Future Trends
by: Pengbo Wang, et al.
Published: (2024-01-01)

Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
by: Teresa Krakauer
Published: (2019-03-01)

Bacterial Superantigen Toxins, CD28, and Drug Development
by: Raymond Kaempfer
Published: (2018-11-01)